fbpx

Would you trust a COVID-19 vaccine made available to the public by 2021?

COVID-19 continues to be a healthcare focus as we enter autumn with organisations around the world racing towards a COVID-19 vaccine.

COVID-19 continues to be a healthcare focus as we enter autumn with organisations around the world racing towards a COVID-19 vaccine. Vaccine development and testing usually takes much longer, but this month, the University Of Oxford’s vaccine expanded into US Phase III clinical trials with 30,000 volunteers.

In Russia, the Sputnik V vaccine was approved prior to the completion of phases 1 and 2, and before phase 3 had started.

Britain has already signed deals for more than 340 million doses of a coronavirus vaccine that is likely to be provided in the second half of 2021. Some experts are concerned that the vaccines developed and brought to market for COVID-19 will be risky due to condensed testing and unknown long-term effects.

In September, we asked our panel members in the United Kingdom, Germany and Spain: “Would you trust a COVID-19 vaccine made available to the public by 2021?”. 

United Kingdom

Germany

Spain

Have your voice heard on relevant healthcare topics.

Join today and take part in paid market research studies!

Leave a Reply

Join Today

Registration is free and only takes a few clicks

Panel Members

Check your available studies

latest posts

emerging respiratory treatments for lung cancer - cystic fibrosis - robotic navigation - gene-editing nanoparticles

Emerging Respiratory Treatments: Frontiers in Pulmonology

Emerging respiratory medicines and treatments, including robotic navigation and gene-editing nanoparticles, may significantly improve patient outcomes in the future for prevalent pulmonary diseases like lung cancer, cystic fibrosis, and chronic obstructive pulmonary disease.

Paid Studies About Medical Devices | M3 Guide

Real-World Evidence studies collect real-world data to evaluate the safety and performance of medical devices. This M3 Guide reveals how we conduct Real-World Evidence studies, how they contribute to better patient outcomes, and how healthcare professionals can get compensated.